{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:29:13Z","timestamp":1778509753412,"version":"3.51.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00514","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:34:15Z","timestamp":1587429255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["New Insights Into the Complex Mutational Landscape of S\u00e9zary Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Abu-Sayeef","family":"Mirza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Horna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie K.","family":"Teer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratilal","family":"Akabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","article-title":"Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in S\u00e9zary syndrome and mycosis fungoides","volume":"147","author":"Mao","year":"2002","journal-title":"Br J Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1600-0560.1998.tb01766.x","article-title":"Comparative analysis of histological and immunohistological features in mycosis fungoides and S\u00e9zary syndrome","volume":"25","author":"Kamarashev","year":"1998","journal-title":"J Cutan Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with S\u00e9zary syndrome","volume":"113","author":"Van Doorn","year":"2009","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","article-title":"Novel and highly recurrent chromosomal alterations in S\u00e9zary syndrome","volume":"68","author":"Vermeer","year":"2008","journal-title":"Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous t cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"Da Silva Almeida","year":"2015","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"39627","DOI":"10.18632\/oncotarget.17383","article-title":"Genetic rearrangements result in altered gene expression and novel fusion transcripts in S\u00e9zary syndrome","volume":"8","author":"Izykowska","year":"2017","journal-title":"Oncotarget."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","article-title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (P.Q575E)","volume":"130","author":"Park","year":"2017","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jid.2016.04.027","article-title":"S\u00e9zary syndrome: translating genetic diversity into personalized medicine","volume":"136","author":"Chevret","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous t cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4067\/S0716-97602011000100012","article-title":"New insights into the roles of megalin\/LRP2 and the regulation of its functional expression","volume":"44","author":"Marzolo","year":"2011","journal-title":"Biol Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/membranes4030333","article-title":"The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells","volume":"4","author":"De","year":"2014","journal-title":"Membranes (Basel)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/pcmr.12352","article-title":"Melanoma tumors frequently acquire lRP2\/megalin expression, which modulates melanoma cell proliferation and survival rates","volume":"28","author":"Andersen","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1158\/1078-0432.CCR-07-4566","article-title":"Association of megalin genetic polymorphisms with prostate cancer risk and prognosis","volume":"14","author":"Holt","year":"2008","journal-title":"Clin Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuint.2009.03.001","article-title":"The human GLUD2 glutamate dehydrogenase: localization and functional aspects","volume":"55","author":"Zaganas","year":"2009","journal-title":"Neurochem Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1038\/srep02256","article-title":"Novel insights into breast cancer genetic variance through RNA sequencing","volume":"3","author":"Horvath","year":"2013","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10815-016-0654-z","article-title":"The poly(A)-binding protein genes, EPAB, PABPC1, and PABPC3 are differentially expressed in infertile men with non-obstructive azoospermia","volume":"33","author":"Ozturk","year":"2016","journal-title":"J Assist Reprod Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jamcollsurg.2018.01.059","article-title":"Whole-exome sequencing identifies two discrete druggable signaling pathways in follicular thyroid cancer","volume":"226","author":"Erinjeri","year":"2018","journal-title":"J Am Coll Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1182\/blood-2012-04-423061","article-title":"Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts","volume":"120","author":"Lee","year":"2012","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/TA.0000000000001593","article-title":"Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation: results from the biochronicity project","volume":"83","author":"Black","year":"2017","journal-title":"J Trauma Acute Care Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1189\/jlb.3MR0117-033R","article-title":"The IL-31\/IL-31 receptor axis: general features and role in tumor microenvironment","volume":"102","author":"Ferretti","year":"2017","journal-title":"J Leukoc Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","article-title":"Comprehensive analysis of PEN status in S\u00e9zary syndrome","volume":"122","author":"Cristofoletti","year":"2013","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood.V114.22.2645.2645","article-title":"Analysis of the PI3\/Akt\/Survivin pathway in acute myelogenous leukemia","volume":"114","author":"Serrano","year":"2009","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/leu.2016.9","article-title":"Pre-BCR signaling in precursor b-cell acute lymphoblastic leukemia regulates PI3K\/AKT, FOXO1, and MYC, and can be targeted by SYK inhibition","volume":"30","author":"K\u00f6hrer","year":"2016","journal-title":"Leukemia."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","article-title":"Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in S\u00e9zary syndrome identified by gene expression analysis","volume":"64","author":"Van Doorn","year":"2004","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","article-title":"T cell-specific loss of Pten leads to defects in central and peripheral tolerance","volume":"14","author":"Suzuki","year":"2001","journal-title":"Immunity."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood.V126.23.2755.2755","article-title":"Pathway-Directed high throughput drug screen identifies PI3K inhibitors that synergistically potentiate anti-tumor activity of HDAC inhibitors in mycosis fungoides and S\u00e9zary syndrome","volume":"126","author":"Ai","year":"2015","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer","volume":"18","author":"Brooks","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","article-title":"FGFR a promising druggable target in cancer: molecular biology and new drugs","volume":"113","author":"Porta","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jid.2016.03.024","article-title":"Identification of gene mutations and fusion genes in patients with S\u00e9zary syndrome","volume":"136","author":"Prasad","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2133.2012.10918.x","article-title":"The tumour suppressor P53 is frequently nonfunctional in S\u00e9zary syndrome","volume":"167","author":"Lamprecht","year":"2012","journal-title":"Br J Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/cco.2018.11.02","article-title":"S\u00e9zary syndrome, recent biomarkers and new drugs","volume":"8","author":"Cristofoletti","year":"2018","journal-title":"Chin Clin Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/CIN.S38044","article-title":"Unraveling the deleterious effects of cancer-Driven STK11 mutants through conformational sampling approach","volume":"15","author":"Lopus","year":"2016","journal-title":"Cancer Inform."},{"key":"B34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12881-017-0471-y","article-title":"Sanger sequencing in exonic regions of sTK11 gene uncovers a novel de-novo germline mutation (c.962_963delCC) associated with Peutz-Jeghers syndrome and elevated cancer risk: case report of a chinese patient","volume":"18","author":"Zhao","year":"2017","journal-title":"BMC Med Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/JTO.0000000000000173","article-title":"LKB1 loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT","volume":"9","author":"Kaufman","year":"2014","journal-title":"J Thorac Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"a000778","DOI":"10.1101\/mcs.a000778","article-title":"Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant","volume":"3","author":"Parachoniak","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.18632\/oncotarget.14172","article-title":"Whole-exome sequencing identified mutational profiles of high-grade colon adenomas","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget."},{"key":"B38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41422-018-0044-4","article-title":"MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models","volume":"28","author":"Xue","year":"2018","journal-title":"Cell Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1158\/1078-0432.CCR-04-0885","article-title":"MAP2K4\/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course","volume":"10","author":"Xin","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"Ellis","year":"2012","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/PAS.0000000000000568","article-title":"Melanomas associated with blue nevi or mimicking cellular blue nevi: clinical, pathologic, and molecular study of 11 cases displaying a high frequency of GNA11 mutations, BAP1 expression loss, and a predilection for the scalp","volume":"40","author":"Costa","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/aos.13452","article-title":"Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma","volume":"96","author":"Staby","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/onc.2013.418","article-title":"Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene."},{"key":"B45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"B46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.blre.2017.03.001","article-title":"p53 dysregulation in B-cell malignancies: more than a single gene in the pathway to hell","volume":"31","author":"Tessoulin","year":"2017","journal-title":"Blood Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/onc.2016.262","article-title":"FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of P53","volume":"36","author":"Molinuevo","year":"2017","journal-title":"Oncogene."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00514\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:34:16Z","timestamp":1587429256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00514\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":47,"alternative-id":["10.3389\/fonc.2020.00514"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00514","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"article-number":"514"}}